The old adage, “you are what you eat” might have special relevance for veterans suffering from Gulf War Illness, a neurological disorder in veterans who served in the Persian Gulf War from 1990 to 1991.
The DoD is on the attack against a wily and deadly enemy that has killed hundreds of thousands of Americans, devastated populations in cities, and destroyed significant segments of the economy.
The VA’s new prescribing guidance for continuous glucose monitors significantly expands the number of veterans with diabetes who are eligible for the devices.
Public health officials across the country have warned that the combination of the COVID-19 pandemic and influenza could endanger a record number of Americans and overwhelm healthcare facilities this fall and winter.
Non-Hispanic Black and Hispanic veterans were twice as likely as non-Hispanic white veterans to test positive for COVID-19 at the VA, even after accounting for other demographics, geographic location and underlying health conditions.
SALT LAKE CITY, UT – Since the release of the National LymphoCare Study nearly 10 years ago, few studies have described real-world practice patterns and clinical outcomes in patients with follicular lymphoma, including the use of maintenance rituximab therapy in the...
SACRAMENTO, CA – What are the complement depleting effects of humanized monoclonal antibodies and the impact of complement replacement on treatment response in patients with hard-to-treat chronic lymphocytic leukemia? A small phase 2 trial published in the Journal of...
HORSHAM, PA -- Chronic lymphocytic leukemia/small lymphocytic lymphoma is the most common adult leukemia, accounting for about 37% of all leukemias in the United States. Yet, a new study suggested that limited real-word evidence is available on the outcomes of...
While the number of COVID-19 cases being actively treated at VA facilities declined, the total number of infections and deaths rose steadily in July and August.
WASHINGTON — Even as VA facilities open up nationwide, administrators and others are keeping a wary eye on the possibility of a significant second wave of the COVID-19 pandemic in the fall. U.S. healthcare systems are preparing now for a sharp increase in cases in the...
Many mental health programs will not accept patients with active substance use issues. That effectively denies treatment to many veterans who have served in the past 20 years, among whom co-occurring substance use disorders and mental health disorders are particularly common.
Schizophrenia can be frightening and life-changing. Common symptoms such as disorganized thinking and speech, lack of expressive emotion, social withdrawal, neglect of self-care, hallucinations and delusions alienate individuals with schizophrenia from others and create barriers to day-to-day functioning in society.
The neutrophil-to-lymphocyte ratio (NLR) biomarker is associated with systemic inflammation and poor prognosis in solid tumors.
Military personnel often have more exposure to sunlight, compared to their civilian counterparts, and that can increase their risk of melanoma.
Past research has cautioned about the risk of skin cancer with use of immunosuppressive medications. Yet, a new study pointed out, there is limited information on repeated basal cell cancer (BCC) occurrences among inflammatory bowel disease (IBD) patients, especially those who use immunosuppressive medications.
While reports in the literature are increasing about high rates of coagulopathy and venous thromboembolism (VTE) among hospitalized patients with coronavirus disease 2019 (COVID-19), there is little guidance on how to treat it or prevent it.
Because VHA provides a continuum of care over the life course, the healthcare system has need to better understand what effect bipolar disorder and schizophrenia have on veterans’ risk of dementia.
Does early adolescent binge drinking (BD) increases the risk for and/or severity of psychopathology in post-9/11 veterans, and how does mild traumatic brain injury (mTBI) affect the risk?